Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-17
1997-03-11
Owens, Amelia A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514325, 546226, A61K 31445, C07D21106
Patent
active
056101651
ABSTRACT:
N-Acylpiperidines of general structure ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis.
REFERENCES:
patent: 4804661 (1989-02-01), Ferrini et al.
patent: 5019576 (1991-05-01), Braquet et al.
patent: 5064838 (1991-11-01), Carr et al.
patent: 5292726 (1994-03-01), Ashton et al.
Lowe, et al., "The Discovery of (2S,3S)-cis)-2-(Diphenylmethyl)-N-[(2-methoxphenyl) methyl]-2-azabicyclo [2.2.2.]-octan-3-amine . . .", J. Med. Chem. 35, pp. 2591-2600 (1992).
Lowe, et al., "Substance P Antagonists", Drug News Perspect., 5(4), pp. 223-227, (1992).
Mills, et al., "1,4-Diacylpiperazine-2-(S)-[(N-Aminoalkyl)Carboxamides], as Novel, . . .", Bioorganic & Medicinal Chemistry Letters, 3(12), pp. 2707-2712, (1993).
Maccoss Malcolm
Mills Sander G.
Merck & Co. , Inc.
Owens Amelia A.
Rose David L.
Thies J. Eric
LandOfFree
N-acylpiperidine tachykinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acylpiperidine tachykinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acylpiperidine tachykinin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-443798